Title: Lymph Node Ratio as an Independent Prognostic Factor in Breast Cancer: A Retrospective Study of 4060 Patients Undergoing Axillary Lymph Node Dissection
Clinical Breast Cancer · 2026
DOI: 10.1016/j.clbc.2026.02.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026. Verfasst von Ashutosh Mishra und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Dr BRA-IRCH, All India Institute of Medical Sciences, New Delhi, Delhi, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymph Node Excision, Lymph Node Ratio, Lymph Nodes. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Pathological nodal (pN) staging in breast cancer is based on the number of positive nodes but may be influenced by surgical extent and technique. Lymph node ratio (LNR)-the ratio of positive to total nodes-accounts for both tumor burden and nodal yield, potentially improving prognostic accuracy. METHODS: We retrospectively analyzed data from 4060 breast cancer patients who underwent axillary lymph node dissection (ALND) between 1995 and 2021 at a tertiary cancer center in India. Disease-free survival (DFS) and overall survival (OS) were assessed using Kaplan-Meier curves and log-rank tests. Correlation analysis and multivariate analysis were used to compare prognostic utility of LNR versus pN stage. Optimal LNR cutoffs were identified using Youden's index. RESULTS: The median follow-up was 93.8 months. On multivariate analysis, LNR retained a strong independent prognostic value for both DFS (HR = 2.00 for LNR 0.2-0.5; HR = 3.29 for LNR > 0.5; P 0.5; P 0.50) showed significantly different survival outcomes (log-rank P < 0.001). CONCLUSIONS: LNR is a superior and independent prognostic marker compared to pN stage in breast cancer patients undergoing ALND. Incorporating LNR into prognostic models may enhance risk stratification and guide adjuvant treatment decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology, Dr BRA-IRCH, All India Institute of Medical Sciences, New Delhi, Delhi, India.
- Department of Surgical Oncology, Dr BRA-IRCH, All India Institute of Medical Sciences, New Delhi, Delhi, India. Electronic address: svsdeo@yahoo.co.in.
- Department of Medical Oncology, Dr BRA-IRCH, All India Institute of Medical Sciences, New Delhi, Delhi, India.
- Department of Radiation Oncology, Dr BRA-IRCH, All India Institute of Medical Sciences, New Delhi, Delhi, India.
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, Delhi, India.
Zitieren
APA
Mishra, A., Deo, S., Bagla, C., Bhoriwal, S., Sharma, J., Kumar, N., Saikia, J., Bansal, B., Kumar, S., Gogia, A., Batra, A., Sharma, D. N., & Mathur, S. (2026). Title: Lymph Node Ratio as an Independent Prognostic Factor in Breast Cancer: A Retrospective Study of 4060 Patients Undergoing Axillary Lymph Node Dissection. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.02.014
Vancouver
Mishra A, Deo S, Bagla C, Bhoriwal S, Sharma J, Kumar N, et al. Title: Lymph Node Ratio as an Independent Prognostic Factor in Breast Cancer: A Retrospective Study of 4060 Patients Undergoing Axillary Lymph Node Dissection. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2026.02.014
BibTeX
@article{Mishra2026,
author = {Mishra, Ashutosh and Deo, Svs and Bagla, Chinmay and Bhoriwal, Sandeep and Sharma, Jyoti and Kumar, Naveen and Saikia, Jyoutishman and Bansal, Babul and Kumar, Sunil and Gogia, Ajay and Batra, Atul and Sharma, D N and Mathur, Sandeep},
title = {Title: Lymph Node Ratio as an Independent Prognostic Factor in Breast Cancer: A Retrospective Study of 4060 Patients Undergoing Axillary Lymph Node Dissection},
journal = {Clinical Breast Cancer},
year = {2026},
doi = {10.1016/j.clbc.2026.02.014}
}
EUVIMED